Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy

Clinical Therapeutics

Volumn 32, Issue 1, 2010, Pages 57-59

  Caldarola, Giacomo ^a   Battista, Claudia ^a   Pellicano, Riccardo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

estrogens; growth hormone; hormonal therapy; melanoma; replacement therapy; thyroid hormones

Indexed keywords

ESTROGEN; HUMAN GROWTH HORMONE; THYROID HORMONE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; FEMALE; HUMAN; MELANOMA; PATHOLOGY; SKIN TUMOR;

ADULT; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MELANOMA; SKIN NEOPLASMS; THYROID HORMONES;

MLCS; MLOWN;

EID: 77952306729     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.01.011     Document Type: Article

References (17)

1. Tucker, MA, Melanoma epidemiology. Hematol Oncol Clin North Am. 23 (2009), 383–395.
2. Tucker, MA, Melanoma epidemiology. Hematol Oncol Clin North Am., 23, 2009, vii.
3. de Giorgi, V, Mavilia, C, Massi, D, et al. The role of estrogens in melanoma and skin cancer. Carcinogenesis., 30, 2009, 720.
4. Leslie, KK, Espey, E, Oral contraceptives and skin cancer: Is there a link?. Am J Clin Dermatol. 6 (2005), 349–355.
5. Koomen, ER, Joosse, A, Herings, RM, et al. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: A populationbased case-control study. Ann Oncol. 20 (2009), 358–364.
6. Clayton, PE, Cowell, CT, Safety issues in children and adolescents during growth hormone therapy—A review. Growth Horm IGF Res. 10 (2000), 306–317.
7. Cowell, CT, Dietsch, S, Adverse events during growth hormone therapy. J Pediatr Endocrinol Metab. 8 (1995), 243–252.
8. Jenkins, PJ, Mukherjee, A, Shalet, SM, Does growth hormone cause cancer?. Clin Endocrinol (Oxf). 64 (2006), 115–121.
9. Naranjo, CA, Busto, U, Sellers, EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30 (1981), 239–245.
10. Corcuff, JB, Ogor, C, Kerlan, V, et al. Ocular naevus and melanoma in acromegaly. Clin Endocrinol (Oxf). 47 (1997), 119–121.
11. Bourguignon, JP, Piérard, GE, Ernould, C, et al. Effects of human growth hormone therapy on melanocytic naevi. Lancet. 341 (1993), 1505–1506.
12. Zvulunov, A, Wyatt, DT, Laud, PW, Esterly, NB, Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol. 137 (1997), 545–548.
13. Zvulunov, A, Wyatt, DT, Laud, PW, Esterly, NB, Influence of genetic and environmental factors on melanocytic naevi: A lesson from Turner's syndrome. Br J Dermatol. 138 (1998), 993–997.
14. Wyatt, D, Melanocytic nevi in children treated with growth hormone. Pediatrics. 104 (1999), 1045–1050.
15. Lincoln, DT, Sinowatz, F, Temmim-Baker, L, et al. Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol. 109 (1998), 141–159.
16. Ginarte, M, García-Caballero, T, Fernández-Redondo, V, et al. Expression of growth hormone receptor in benign and malignant cutaneous proliferative entities. J Cutan Pathol. 27 (2000), 276–282.
17. Lincoln, DT, Sinowatz, F, Kölle, S, et al. Up-regulation of growth hormone receptor immunoreactivity in human melanoma. Anticancer Res. 19 (1999), 1919–1931.